{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidnbd7znzpgfupr33tvromcja3yyl4roisyl6idy6auz6xygte5um",
    "uri": "at://did:plc:izotgtw5czjnuqtpcldjnkjh/app.bsky.feed.post/3mhbfmpk3l272"
  },
  "path": "/a-promising-fatty-liver-treatment-may-actually-trigger-cancer/",
  "publishedAt": "2026-03-17T16:29:51.000Z",
  "site": "https://scitechdaily.com",
  "tags": [
    "Health",
    "Biomedical Engineering",
    "Cancer",
    "Cell Biology",
    "Genetics",
    "Liver",
    "University of Adelaide"
  ],
  "textContent": "A new study suggests that suppressing a cellular enzyme long considered protective against fatty liver disease could have unexpected long-term consequences. Scientists have uncovered a troubling tradeoff in the liver. An enzyme called Caspase-2 has attracted attention as a possible target for fatty liver disease, but new evidence suggests shutting it down could make the [...]",
  "title": "A Promising Fatty Liver Treatment May Actually Trigger Cancer"
}